New 'Living Drug' tested as last hope for tough blood cancers
NCT ID NCT03853616
Summary
This is an early-stage safety study testing a new type of personalized cell therapy called MB-CART19.1. It aims to find a safe dose for adults and children whose B-cell blood cancers (like leukemia or lymphoma) have returned or not responded to standard treatments. The therapy involves collecting a patient's own immune cells, modifying them in a lab to better target cancer, and then infusing them back into the patient.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL LYMPHOMA REFRACTORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - University clinic, pediatric clinic with focus on oncology and hematology
Berlin, 13353, Germany
-
Children's Hospital of Dr. von Hauner by Ludwig-Maximilian University
Munich, 80337, Germany
-
Tuebingen University clinic, medical university clinic for internal medicine
Tübingen, 72076, Germany
-
University clinic for children and youth medicine
Tübingen, 72076, Germany
-
University clinic, pediatric hematology and oncology
Würzburg, 97070, Germany
-
University medicine Goettingen, Clinic of hematology and medical oncology
Göttingen, 37075, Germany
-
Universitätsklinikum Erlangen
Erlangen, 91054, Germany
-
Universitätsklinikum Münster - Klink für Kinderheilkunde und Jugendmedizin / Pädiatrische Hämatologie und Onkologie
Münster, 48149, Germany
-
Universitätsklinikum Münster - Medizinische Klinik A / KMT Zentrum
Münster, 48149, Germany
Conditions
Explore the condition pages connected to this study.